Bellevue Group AG Q4 2016 Filing
Filed February 10, 2017
Portfolio Value
$488.3B
Holdings
122
Report Date
Q4 2016
Filing Type
13F-HR
All Holdings (122 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | —GW PHARMACEUTICALS PLC | 6,000 | $670.0M | 0.14% | |
| 102 | DVADAVITA INC | 10,000 | $642.0M | 0.13% | |
| 103 | NVROEURNEVRO CORP | 8,700 | $632.0M | 0.13% | |
| 104 | —KITE PHARMA INC | 14,000 | $628.0M | 0.13% | |
| 105 | VAREURVARIAN MED SYS INC | 7,000 | $628.0M | 0.13% | |
| 106 | —CELLDEX THERAPEUTICS INC NEW | 160,000 | $566.0M | 0.12% | |
| 107 | PODDINSULET CORP | 15,000 | $565.0M | 0.12% | |
| 108 | —REWALK ROBOTICS LTD | 200,000 | $560.0M | 0.11% | |
| 109 | —QUOTIENT LTD | 110,000 | $532.0M | 0.11% | |
| 110 | ESPRESPERION THERAPEUTICS INC NEW | 40,000 | $501.0M | 0.10% | |
| 111 | RMERESMED INC | 8,000 | $496.0M | 0.10% | |
| 112 | TBPHTHERAVANCE BIOPHARMA INC | 15,428 | $492.0M | 0.10% | |
| 113 | NVAXNOVAVAX INC | 325,000 | $410.0M | 0.08% | |
| 114 | —HORIZON PHARMA PLC | 24,000 | $388.0M | 0.08% | |
| 115 | —WEBMD HEALTH CORP | 7,400 | $367.0M | 0.08% | |
| 116 | —OBALON THERAPEUTICS INC | 40,000 | $354.0M | 0.07% | |
| 117 | —AAC HLDGS INC | 45,000 | $326.0M | 0.07% | |
| 118 | PENPENUMBRA INC | 5,000 | $319.0M | 0.07% | |
| 119 | SGRYSURGERY PARTNERS INC | 15,000 | $238.0M | 0.05% | |
| 120 | MYGNMYRIAD GENETICS INC | 14,000 | $233.0M | 0.05% | |
| 121 | —WRIGHT MED GROUP NV | 10,000 | $230.0M | 0.05% | |
| 122 | CLDNEUREIGER BIOPHARMACEUTICALS INC | 3,333 | $39.0M | 0.01% |
PreviousPage 2 of 2